vs
Side-by-side financial comparison of Clearwater Paper Corp (CLW) and USANA HEALTH SCIENCES INC (USNA). Click either name above to swap in a different company.
Clearwater Paper Corp is the larger business by last-quarter revenue ($360.3M vs $250.2M, roughly 1.4× USANA HEALTH SCIENCES INC). USANA HEALTH SCIENCES INC runs the higher net margin — 3.0% vs -3.6%, a 6.6% gap on every dollar of revenue. On growth, USANA HEALTH SCIENCES INC posted the faster year-over-year revenue change (-3.0% vs -4.7%). Over the past eight quarters, USANA HEALTH SCIENCES INC's revenue compounded faster (11.8% CAGR vs 2.3%).
Clearwater Paper Corporation is an American pulp and paperboard manufacturer. The company was created on December 9, 2008, via a spin-off from Potlatch Corporation and is headquartered in Spokane, Washington.
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
CLW vs USNA — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2027
| Metric | | |
|---|---|---|
| Revenue | $360.3M | $250.2M |
| Net Profit | $-12.8M | $7.5M |
| Gross Margin | -0.2% | 76.2% |
| Operating Margin | — | 5.5% |
| Net Margin | -3.6% | 3.0% |
| Revenue YoY | -4.7% | -3.0% |
| Net Profit YoY | -103.2% | -20.0% |
| EPS (diluted) | — | $0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $360.3M | $250.2M | ||
| Q4 25 | $386.4M | $226.2M | ||
| Q3 25 | $399.0M | $213.7M | ||
| Q2 25 | $391.8M | $235.8M | ||
| Q1 25 | $378.2M | $249.5M | ||
| Q4 24 | $387.1M | $213.6M | ||
| Q3 24 | $393.3M | $200.2M | ||
| Q2 24 | $344.4M | — |
| Q1 26 | $-12.8M | $7.5M | ||
| Q4 25 | $38.3M | $180.0K | ||
| Q3 25 | $-53.3M | $-6.5M | ||
| Q2 25 | $2.7M | $9.7M | ||
| Q1 25 | $-6.3M | $9.4M | ||
| Q4 24 | $199.1M | $4.5M | ||
| Q3 24 | $5.8M | $10.6M | ||
| Q2 24 | $-25.8M | — |
| Q1 26 | -0.2% | 76.2% | ||
| Q4 25 | 4.5% | 78.2% | ||
| Q3 25 | 4.7% | 77.2% | ||
| Q2 25 | 11.0% | 78.7% | ||
| Q1 25 | 9.7% | 79.0% | ||
| Q4 24 | 3.8% | 82.0% | ||
| Q3 24 | 7.7% | 80.4% | ||
| Q2 24 | -0.6% | — |
| Q1 26 | — | 5.5% | ||
| Q4 25 | 1.9% | 1.7% | ||
| Q3 25 | -13.9% | 0.6% | ||
| Q2 25 | 2.5% | 7.1% | ||
| Q1 25 | -1.1% | 6.3% | ||
| Q4 24 | -4.0% | 3.8% | ||
| Q3 24 | -0.3% | 7.8% | ||
| Q2 24 | -13.6% | — |
| Q1 26 | -3.6% | 3.0% | ||
| Q4 25 | 9.9% | 0.1% | ||
| Q3 25 | -13.4% | -3.1% | ||
| Q2 25 | 0.7% | 4.1% | ||
| Q1 25 | -1.7% | 3.8% | ||
| Q4 24 | 51.4% | 2.1% | ||
| Q3 24 | 1.5% | 5.3% | ||
| Q2 24 | -7.5% | — |
| Q1 26 | — | $0.41 | ||
| Q4 25 | $2.36 | $-0.10 | ||
| Q3 25 | $-3.30 | $-0.36 | ||
| Q2 25 | $0.17 | $0.52 | ||
| Q1 25 | $-0.38 | $0.49 | ||
| Q4 24 | $11.87 | $0.23 | ||
| Q3 24 | $0.35 | $0.56 | ||
| Q2 24 | $-1.55 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.5M | $162.8M |
| Total DebtLower is stronger | $361.1M | — |
| Stockholders' EquityBook value | $813.8M | — |
| Total Assets | $1.6B | $739.0M |
| Debt / EquityLower = less leverage | 0.44× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $36.5M | $162.8M | ||
| Q4 25 | $30.7M | $158.4M | ||
| Q3 25 | $34.4M | $145.3M | ||
| Q2 25 | $46.7M | $151.3M | ||
| Q1 25 | $44.0M | $179.6M | ||
| Q4 24 | $79.6M | $181.8M | ||
| Q3 24 | $35.5M | $364.9M | ||
| Q2 24 | $39.6M | — |
| Q1 26 | $361.1M | — | ||
| Q4 25 | $346.8M | — | ||
| Q3 25 | $337.0M | — | ||
| Q2 25 | $330.1M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $283.4M | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.1B | — |
| Q1 26 | $813.8M | — | ||
| Q4 25 | $825.3M | — | ||
| Q3 25 | $783.0M | $528.1M | ||
| Q2 25 | $836.8M | $531.1M | ||
| Q1 25 | $836.6M | $529.8M | ||
| Q4 24 | $854.6M | $532.1M | ||
| Q3 24 | $664.6M | $533.1M | ||
| Q2 24 | $658.6M | — |
| Q1 26 | $1.6B | $739.0M | ||
| Q4 25 | $1.6B | $742.9M | ||
| Q3 25 | $1.6B | $726.6M | ||
| Q2 25 | $1.6B | $734.5M | ||
| Q1 25 | $1.6B | $746.6M | ||
| Q4 24 | $1.7B | $748.2M | ||
| Q3 24 | $2.5B | $671.3M | ||
| Q2 24 | $2.5B | — |
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.42× | — | ||
| Q3 25 | 0.43× | — | ||
| Q2 25 | 0.39× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.33× | — | ||
| Q3 24 | 1.73× | — | ||
| Q2 24 | 1.74× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
